Researchers discovered that herpes simplex virus type 1 reprograms the brain’s specialized immune cells, triggering aggressive antiviral defenses while shutting down routine maintenance functions. The findings published in PLOS Pathogens show a potential mechanism linking common viral infections to chronic neuroinflammation and Alzheimer’s disease.
Intranasal HSV-1 Infection and Microglial Remodeling
Herpes simplex virus type 1 infects more than 60 percent of the global adult population and remains in the body for life, typically residing quietly within peripheral nerve ganglia. A very common pathogen may alter neurological health long after an initial infection clears. While severe complications remain rare, clinical and epidemiological evidence has long linked the pathogen to chronic neuroinflammation and late-onset Alzheimer’s disease. Despite these observations, the biological pathway connecting a mucosal virus to long-term neurodegenerative risk has remained largely unmapped.
Cold Sore Virus Reprograms Brain Immune Cells
Researchers at the University of Colorado Anschutz Medical Campus set out to examine this mechanism by analyzing living animal models following intranasal infection, which mirrors the natural route through which the virus enters the central nervous system. Using high-resolution single-cell molecular profiling alongside spatial transcriptomics and proteomics, the team mapped how individual resident immune cells respond when the virus infiltrates neural tissue. The results show that the pathogen does not simply provoke a standard inflammatory burst.
Under normal conditions, those resident immune cells serve a dual purpose. When the virus enters the brain, however, those cells adopt an aggressive defense posture.
When HSV-1 enters the brain, these cells shift into emergency defense mode. While this helps fight the virus, it may also compromise their ability to perform the everyday functions, even after the virus is gone.
Christy Niemeyer, University of Colorado Anschutz
Interferon Signaling and Chromatin Alterations in Brainstem Regions.
Brainstem Regions Show Interferon Signaling and Chromatin Alterations
The investigation revealed that exposure to the virus drives microglia into distinct populations dominated by interferon signaling, a potent first-line antiviral cascade. That focused defense creates a steep metabolic trade-off. Genes governing basic homeostatic support, synaptic pruning, and debris-clearing duties are downregulated.
Those alterations are not distributed uniformly across the entire brain. Instead, researchers discovered that the changes concentrate tightly in discrete microenvironments where viral antigen is physically present, creating localized focal zones of immune activation. Spatial data confirmed that the brainstem regions harboring viral antigen align precisely with territories enriched for predicted regulatory targets including STAT1/2, IRF1, and CEBPB. Astrocytes also adopt reactive states within those exact territories.
Further epigenetic analysis demonstrated that viral exposure reorganizes chromatin, the structural packaging of DNA inside the cell nucleus. By changing which sections of DNA remain open or closed to transcription machinery, the infection alters the underlying molecular programming of the immune cells. What makes these findings particularly interesting is that the virus isn’t simply triggering inflammation,
Niemeyer noted. It’s changing the molecular programs that control how these immune cells function. An important question is whether these changes persist after infection.
Herpes Virus Remodels Brain Immune Cells
Implications for Alzheimer’s Disease and Next Research Steps.
The study provides a mechanistic model for how repeated subclinical viral reactivations across a lifetime could influence long-term brain health. Although we have not established that HSV-1 causes Alzheimer’s, it highlights the immune programming of microglia as a common factor linking infection, aging and genetic risk factors,
said Christy Niemeyer.
Because Alzheimer’s disease is influenced by multiple genetic and environmental factors, understanding how a common virus alters the brain’s immune environment may help investigators identify why specific individuals exhibit higher vulnerability to neurodegeneration. The research team is now preparing follow-up studies to investigate whether those microglial chromatin alterations persist after infection and how intermittent viral reactivations influence long-term brain health.